VELGENLEA Trademark

Trademark Overview

On Wednesday, February 9, 2022, a trademark application was filed for VELGENLEA with the United States Patent and Trademark Office. The USPTO has given the VELGENLEA trademark a serial number of 97260204. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Wednesday, January 22, 2025. This trademark is owned by Regeneron Pharmaceuticals, Inc.. The VELGENLEA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of ophthalmological diseases and disorders
velgenlea

General Information

Serial Number97260204
Word MarkVELGENLEA
Filing DateWednesday, February 9, 2022
Status733 - FOURTH EXTENSION - GRANTED
Status DateWednesday, January 22, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 1, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of ophthalmological diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 15, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRegeneron Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591
Party NameRegeneron Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591

Trademark Events

Event DateEvent Description
Saturday, February 12, 2022NEW APPLICATION ENTERED
Tuesday, February 15, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 14, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 14, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 14, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, September 26, 2022ASSIGNED TO EXAMINER
Monday, September 26, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 12, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 1, 2022PUBLISHED FOR OPPOSITION
Tuesday, November 1, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 27, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, May 26, 2023SOU TEAS EXTENSION RECEIVED
Friday, May 26, 2023SOU EXTENSION 1 FILED
Friday, May 26, 2023SOU EXTENSION 1 GRANTED
Tuesday, May 30, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 14, 2023SOU TEAS EXTENSION RECEIVED
Thursday, December 14, 2023SOU EXTENSION 2 FILED
Thursday, January 4, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, January 5, 2024SOU EXTENSION 2 GRANTED
Saturday, January 6, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 29, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, May 29, 2024SOU EXTENSION 3 GRANTED
Thursday, May 30, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 13, 2024SOU EXTENSION 4 FILED
Wednesday, January 22, 2025SOU EXTENSION 4 GRANTED
Thursday, January 23, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 29, 2024SOU EXTENSION 3 FILED
Friday, December 13, 2024SOU TEAS EXTENSION RECEIVED

Related Keywords

velgenlea diseases disorders ophthalmological treatment preparations pharmaceutical